Bone Marrow Engraftment Printer Friendly
back Clinical Background Clinical Utility Assay Principle Results Sample Requirements Case Tutorial References forward
  Written by: Karin Berg, M.D.


Clinical Background:

Allogeneic BMT is a common treatment used with curative intent in patients with a variety of hematologic malignancies arising in bone marrow derived cells. Effective therapy requires:

  • Complete myeloablation of the patient’s bone marrow
  • A donor, preferably living-related and HLA matched to the patient
  • A short period of immunosuppresion of the recipient after transplantation
  








Homepage | Site Info | Contact Us | Links | Search

Pathology Homepage
 Copyright © 1999 - 2005 The Johns Hopkins University
All rights reserved. No part of this website may be reproduced in any
form or by any means or incorporated into any information retrievel system,
electronic or mechanical, without the written permission of JHU.